Dr. Halperin Wernli will be tasked with expanding the clinical and scientific team in Europe. Her immediate primary leadership responsibilities center around the company’s LSD microdosing program and Project Lucy, the LSD experiential therapy program for anxiety disorders. Dr. Halperin Wernli will also help implement R&D collaborations in Europe which include the company’s partnership with the... Read more
Mydecine Innovations Group Featured in Forbes for the First-Of-Its-Kind Clinicals Using Psilocybin Therapy For PTSD
Ryan Allway August 13th, 2020 Psychedelics, Top News DENVER, Aug. 13, 2020 (GLOBE NEWSWIRE) — Mydecine Innovations Group Inc. (CSE:MYCO) (OTC:MYCOF) (FSE:0NFA) (“Mydecine” or the “Company”), is pleased to announce that NeuroPharm Inc., a company focused on developing unique mental health therapies and approaches for veteran wellness, was recently covered in... Read more
GRAPH BLOCKCHAIN ENTERS INTO A BINDING LETTER OF INTENT TO ACQUIRE THIRD EYE INSIGHTS CORP
Ryan Allway August 7th, 2020 Psychedelics Toronto, Ontario–(Newsfile Corp. – August 6, 2020) – Graph Blockchain Inc. (CSE: GBLC) (“Graph” or the “Company“) announces it has entered into a binding letter of intent (“LOI”) in connection with the proposed acquisition of Third Eye Insights Corp. (“Third Eye” or “Seller”), to acquire 100%... Read more
Nutritional High Announces Settlement of Payables and Update on Psychedelic Sciences Corp Acquisition.
Ryan Allway August 6th, 2020 Psychedelics Nutritional High International Inc. (EAT) (OTC Pink: SPLIF) (“Nutritional High” or the “Company“) is pleased to announce settlement of trade payables and an update regarding the acquisition of Psychedelic Sciences Corp (“PSC“). The Company announces that trade creditors representing CAD $1,159,936 have entered into settlement... Read more
Red Light Holland Commences Magic Truffles Growth Operation in the Netherlands, Months Ahead of Schedule
Ryan Allway August 6th, 2020 Psychedelics Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (“Red Light Holland” or the “Company“), an Ontario-based corporation positioning itself to engage in the production, growth and sale of a its brand of magic truffles to the legal, recreational market within the Netherlands (initially, in... Read more
NeonMind Submits Application for Psilocybin Research to Health Canada
Ryan Allway August 6th, 2020 Psychedelics The Yield Growth Corp. (CSE:BOSS) (OTCQB:BOSQF) (FE:YG3) majority owned subsidiary NeonMind Biosciences Inc. (“NeonMind”) announces submission of an application to Health Canada for an exemption to use a controlled substance for scientific purposes, pursuant to Section 56(1) of the Controlled Drugs and Substances Act, S.C.... Read more
Mindset Pharma Announces Filing of Groundbreaking Psilocybin Synthesis Patent
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
4 Palliative Canadians approved for end of life psilocybin therapy through section 56(1) ; First legal medical exemptions for psilocybin in Canada since 1970’s
Ryan Allway August 5th, 2020 Psychedelics Four Canadians battling incurable cancer have been approved by the Minister of Health, Patty Hajdu, to use psilocybin therapy in the treatment of their end-of-life distress. These 4 patients mark the first publicly-known individuals to receive a legal exemption from the Canadian Drugs... Read more
Why Extracts Are the Key to Plant-based Medicine
Ryan Allway July 30th, 2020 App, Exclusive, Psychedelics, Top Story Plants have long been a source of beneficial pharmaceutical compounds, but extraction transformed these plants into the medicines that we know today. With the rapid growth in the cannabis and psychedelic industries, investors may want to keep an eye... Read more
DENVER, July 24, 2020 /PRNewswire/ — Mydecine Innovations Group Inc. (CSE: MYCO) (OTC: MYCOF) (FSE: 0NF) (“Mydecine” or the “Company”), is pleased to announce that they have hired former Red Bull marketing executive, Jim Gunning, as the Company’s new Chief Marketing Officer (“CMO”). “When I was first contacted by Damon Michaels, the company’s Chief Operations... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )